A2 Milk (ASX:A2M) share price on watch after US FDA approval
The A2 Milk Company Ltd (ASX:A2M) share price is in focus today after the business announced FDA approval in the US.
Looking for growth in 2020 and beyond? Here are the latest ASX growth stock ideas, stories and news from our team at Rask Media. We think it’s fair to say that Australia’s ASX growth stocks are some of the best in the world, given their potential for international growth and the fact that many Australian companies also offer their dividends with franking credits.
The A2 Milk Company Ltd (ASX:A2M) share price is in focus today after the business announced FDA approval in the US.
The S&P/ASX 200 (INDEXASX: XJO) managed a small gain on Wednesday, adding 0.1 per cent, as strength in the energy and materials sectors offset losses in property. Rio Tinto Limited’s (ASX:RIO) interest in Turquoise Hill has got investors thinking.
The CSL Limited (ASX: CSL) share price is in focus today after the biotech giant made a mRNA vaccine announcement.
The EML Payments Ltd (ASX:EML) share price has suffered another massive sell-off, dropping by 27%. Now it’s the UK’s turn to cause pressure.
The Bubs Australia Ltd (ASX:BUB) share price is under the spotlight today after announcing its FY23 first quarter update.
S&P/ASX 200 (INDEXASX: XJO) futures contracts are pointing to a very positive open on Monday morning. Macquarie Group (ASX:MQG) share price is in focus.
Times of uncertainty are unsettling to live through. However, they do create very interesting chances to buy discounted ASX growth shares.
The Lynas Rare Earths Ltd (ASX:LYC) share price is up around 7% after the miner told investors how the first three months of FY23 went.
Wayne Hooper is the CEO of Laserbond Ltd (ASX: LBL), a $90 million business listed on the ASX that performs surface engineering. Wayne Hooper sat down with Owen Rask on The Australian Investors Podcast at Laserbond’s Sydney-based factory in Smeaton Grange.
The A2 Milk Company Ltd (ASX:A2M) share price is in focus today after the business announced FDA approval in the US.
The S&P/ASX 200 (INDEXASX: XJO) managed a small gain on Wednesday, adding 0.1 per cent, as strength in the energy and materials sectors offset losses in property. Rio Tinto Limited’s (ASX:RIO) interest in Turquoise Hill has got investors thinking.
The CSL Limited (ASX: CSL) share price is in focus today after the biotech giant made a mRNA vaccine announcement.
The EML Payments Ltd (ASX:EML) share price has suffered another massive sell-off, dropping by 27%. Now it’s the UK’s turn to cause pressure.
The Bubs Australia Ltd (ASX:BUB) share price is under the spotlight today after announcing its FY23 first quarter update.
S&P/ASX 200 (INDEXASX: XJO) futures contracts are pointing to a very positive open on Monday morning. Macquarie Group (ASX:MQG) share price is in focus.
Times of uncertainty are unsettling to live through. However, they do create very interesting chances to buy discounted ASX growth shares.
The Lynas Rare Earths Ltd (ASX:LYC) share price is up around 7% after the miner told investors how the first three months of FY23 went.
Wayne Hooper is the CEO of Laserbond Ltd (ASX: LBL), a $90 million business listed on the ASX that performs surface engineering. Wayne Hooper sat down with Owen Rask on The Australian Investors Podcast at Laserbond’s Sydney-based factory in Smeaton Grange.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) and Target Market Determination before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024